Guang-ling U. Jie

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.

ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.

Journal: Annals of surgical oncology

Published: August 11, 2026

The dual role of retinoic acid signaling in clear cell renal cell carcinoma and wilms tumor: A tale of two entities.

The dual role of retinoic acid signaling in clear cell renal cell carcinoma and wilms tumor: A tale of two entities.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: April 17, 2026

Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer.

Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer.

Journal: Lung Cancer (Auckland, N.Z.)

Published: January 16, 2026

The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and its Genomic Analysis.

The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and its Genomic Analysis.

Journal: Annals of surgical oncology

Published: August 15, 2025

Plasma proteomics profiling identifies predictive biomarkers for immunotherapy response in small-cell lung cancer.

Plasma proteomics profiling identifies predictive biomarkers for immunotherapy response in small-cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 29, 2025

Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.

Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.

Journal: Nature medicine

Published: November 17, 2023

Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.

Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.

Journal: Therapeutic advances in medical oncology

Published: January 15, 2023

Toward a cure for lung cancer: important advances in operable non-small cell lung cancer.

Toward a cure for lung cancer: important advances in operable non-small cell lung cancer.

Journal: Science bulletin

Published: December 22, 2022

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.

Journal: Cancers

Published: November 24, 2022

Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials.

Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials.

Journal: Expert opinion on emerging drugs

Published: April 06, 2022

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Journal: Cancer medicine

Published: March 20, 2022

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.

Journal: Experimental hematology & oncology

Published: September 18, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026